JENBURKT PHARMACEUTICALS
|
JENBURKT PHARMACEUTICALS Last 5 Year Financial Ratios History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 72.65 | 58.86 | 55.76 | 48.58 | 35.96 |
CEPS(Rs) | 78.83 | 64.16 | 60.88 | 52.72 | 40.39 |
DPS(Rs) | 18.00 | 15.30 | 14.40 | 12.00 | 10.20 |
Book NAV/Share(Rs) | 389.23 | 328.42 | 277.32 | 255.77 | 214.55 |
Tax Rate(%) | 27.02 | 26.15 | 25.13 | 25.35 | 23.75 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 26.63 | 23.33 | 22.21 | 21.98 | 18.15 |
EBIT Margin(%) | 29.26 | 24.97 | 24.30 | 24.44 | 20.23 |
Pre Tax Margin(%) | 28.96 | 24.78 | 24.03 | 24.09 | 19.80 |
PAT Margin (%) | 21.14 | 18.30 | 17.99 | 17.98 | 15.10 |
Cash Profit Margin (%) | 22.93 | 19.95 | 19.65 | 19.52 | 16.96 |
Performance Ratios | |||||
ROA(%) | 17.86 | 17.00 | 17.33 | 16.95 | 14.68 |
ROE(%) | 20.25 | 19.43 | 20.53 | 20.66 | 18.49 |
ROCE(%) | 27.85 | 26.28 | 26.80 | 26.89 | 23.83 |
Asset Turnover(x) | 0.85 | 0.93 | 0.96 | 0.94 | 0.97 |
Sales/Fixed Asset(x) | 4.09 | 4.18 | 4.05 | 3.79 | 3.45 |
Working Capital/Sales(x) | 4.02 | 1.52 | 2.09 | 2.27 | 1.76 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.24 | 0.24 | 0.25 | 0.26 | 0.29 |
Receivable days | 48.38 | 46.84 | 42.93 | 42.99 | 53.15 |
Inventory Days | 20.98 | 21.72 | 24.32 | 25.71 | 30.86 |
Payable days | 101.38 | 84.76 | 84.44 | 77.81 | 64.63 |
Valuation Parameters | |||||
PER(x) | 13.93 | 11.71 | 11.94 | 11.66 | 11.08 |
PCE(x) | 12.83 | 10.75 | 10.94 | 10.75 | 9.86 |
Price/Book(x) | 2.60 | 2.10 | 2.40 | 2.22 | 1.86 |
Yield(%) | 1.78 | 2.22 | 2.16 | 2.12 | 2.56 |
EV/Net Sales(x) | 2.79 | 1.59 | 1.77 | 1.75 | 1.19 |
EV/Core EBITDA(x) | 9.00 | 5.96 | 6.83 | 6.73 | 5.38 |
EV/EBIT(x) | 9.55 | 6.35 | 7.30 | 7.16 | 5.88 |
EV/CE(x) | 2.44 | 1.55 | 1.94 | 1.52 | 1.08 |
M Cap / Sales | 2.94 | 2.14 | 2.15 | 2.10 | 1.67 |
Growth Ratio | |||||
Net Sales Growth(%) | 6.85 | 3.82 | 10.30 | 13.44 | -8.07 |
Core EBITDA Growth(%) | 24.69 | 6.47 | 10.21 | 33.35 | 0.78 |
EBIT Growth(%) | 25.22 | 6.66 | 9.66 | 37.03 | 2.09 |
PAT Growth(%) | 23.42 | 5.57 | 10.36 | 35.11 | 10.98 |
EPS Growth(%) | 23.42 | 5.57 | 14.76 | 35.11 | 10.98 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.01 | - | 0.02 | 0.05 | 0.04 |
Current Ratio(x) | 3.00 | 6.70 | 5.14 | 3.57 | 4.45 |
Quick Ratio(x) | 2.53 | 6.18 | 4.62 | 3.10 | 4.02 |
Interest Cover(x) | 98.02 | 130.99 | 90.55 | 69.76 | 46.69 |
Total Debt/Mcap(x) | - | - | 0.01 | 0.02 | 0.02 |
Compare Financial Ratios of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹584.5 Cr | -2.7% | 0.7% | 50% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -2.7% |
0.7% |
50% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses